Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome
Authors
Keywords
Obesity, Pentraxin-3, Acute coronary syndrome
Journal
Cardiovascular Diabetology
Volume 12, Issue 1, Pages 167
Publisher
Springer Nature
Online
2013-11-11
DOI
10.1186/1475-2840-12-167
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of Plasma Pentraxin 3 With Arterial Stiffness in Overweight and Obese Individuals
- (2013) A. Miyaki et al. AMERICAN JOURNAL OF HYPERTENSION
- Metabolic syndrome and abdominal fat are associated with inflammation, but not with clinical outcomes, in peritoneal dialysis patients
- (2013) Jenq-Wen Huang et al. Cardiovascular Diabetology
- Elevated Levels of Systemic Pentraxin 3 Are Associated With Thin-Cap Fibroatheroma in Coronary Culprit Lesions
- (2013) Seiji Koga et al. JACC-Cardiovascular Interventions
- The association between pentraxin 3 and insulin resistance in obese children at baseline and after physical activity intervention
- (2012) Sang Hui Chu et al. CLINICA CHIMICA ACTA
- High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome
- (2012) Aydogan Aydogdu et al. GYNECOLOGICAL ENDOCRINOLOGY
- Adipokines, Ghrelin and Obesity-Associated Insulin Resistance in Nondiabetic Patients with Acute Coronary Syndrome
- (2012) Rocco Barazzoni et al. Obesity
- Plasma PTX3 protein levels inversely correlate with insulin secretion and obesity, whereas visceral adipose tissue PTX3 gene expression is increased in obesity
- (2011) O. Osorio-Conles et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Inverse Relationship between the Inflammatory Marker Pentraxin-3, Fat Body Mass, and Abdominal Obesity in End-Stage Renal Disease
- (2011) T. Miyamoto et al. Clinical Journal of the American Society of Nephrology
- Pentraxins and Atherosclerosis: The Role of PTX3
- (2011) Cecilia Garlanda et al. CURRENT PHARMACEUTICAL DESIGN
- Reciprocal Contribution of Pentraxin 3 and C-Reactive Protein to Obesity and Metabolic Syndrome
- (2010) Tsuneo Ogawa et al. Obesity
- The Long Pentraxin PTX3: A Modulator of the Immunoinflammatory Response in Atherosclerosis and Cardiovascular Diseases
- (2010) Giuseppe Danilo Norata et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Pentraxin 3 in unstable angina and non-ST-segment elevation myocardial infarction
- (2009) Shigeru Matsui et al. ATHEROSCLEROSIS
- Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis
- (2009) Giuseppe Danilo Norata et al. CIRCULATION
- Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile
- (2009) Michela Zanetti et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Expression of long pentraxin PTX3 in human adipose tissue and its relation with cardiovascular risk factors
- (2008) L. Alberti et al. ATHEROSCLEROSIS
- Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial Infarction
- (2008) Monica Salio et al. CIRCULATION
- The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality
- (2008) M.E. Suliman et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now